Sargent Bickham Lagudis LLC Laboratory Corp Of America Holdings Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 92 shares of LH stock, worth $21,032. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92
Previous 92
-0.0%
Holding current value
$21,032
Previous $19,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding LH
# of Institutions
95Shares Held
1.94MCall Options Held
0Put Options Held
0-
Jana Partners LLC New York, NY402KShares$91.9 Million7.25% of portfolio
-
Cannell & Co. New York, NY341KShares$77.9 Million2.57% of portfolio
-
Bartlett & Co. LLC223KShares$50.9 Million0.82% of portfolio
-
Atlanta Capital Management CO L L C Atlanta, GA198KShares$45.2 Million0.18% of portfolio
-
Credit Suisse Ag Zurich, V8141KShares$32.3 Million0.03% of portfolio
About LABORATORY CORP OF AMERICA HOLDINGS
- Ticker LH
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 89,600,000
- Market Cap $20.5B
- Description
- Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...